Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 12—December 2024
Research

Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh

An Nguyen1, Rebeca Sultana1Comments to Author , Elisabeth Vodicka, Zareen Tasnim, Kamran Mehedi, Md. Monjurul Islam, S.M. Abdullah Al Murad, Md. Redowan Ullah, Sharmin Sultana, Tahmina Shirin, and Clint Pecenka
Author affiliation: Program for Appropriate Technology in Health (PATH), Ho Chi Minh City, Vietnam (A. Nguyen); icddr,b, Dhaka, Bangladesh (R. Sultana, Z. Tasnim, M.R. Ullah); PATH, Seattle, Washington, USA (E. Vodicka, C. Pecenka); PATH, Dhaka (K. Mehedi); Maternal, Newborn, Child and Adolescent Health, Dhaka (M.M. Islam, S.M.A. Al Murad); Institute of Epidemiology Diseases Control and Research, Dhaka (S. Sultana, T. Shirin)

Main Article

Table 4

Discounted incremental costs of different Japanese encephalitis vaccination strategies as compared with no vaccination from the governmental payer and societal perspectives in Bangladesh*

Discounted incremental outcomes
Routine immunization birth cohorts
Strategy 1, subnational campaign + subnational routine†

Strategy 2, subnational campaign + national routine‡

Strategy 3, national routine§
Govt
Soc
Govt
Soc
Govt
Soc
Discounted healthcare costs averted through vaccination
10 5.3M 55.8M 8.5M 90.1M 5.7M 60.1M
20
7.1M
75.1M

12.7M
134.8M

9.9M
104.8M
Deterministic ICER: cost per DALY averted
10 892 23 955 60 1,066 126
20
981
94

1,053
143

1,149
208
Deterministic ICER: cost per case averted
10 9,046 230 9,710 609 10,888 1,283
20
9,964
958

10,720
1,458

11,733
2,128
Deterministic ICER: cost per death averted
10 45,230 1,148 48,549 3,045 54,441 6,413
20
49,819
4,790

53,601
7,290

58,667
10,640
Probabilistic ICER: cost per DALY averted, mean (95% CI)
10 991 (358–2,272) 173 (–632 to 1,719) 1,351 (453–3,469) 196 (–501 to 2,614) 1,374 (439–3,557) 445 (–644 to 2,430)
20
1,198 (444 to 2,807)
307 (–538 to 1,971)

1,249 (352 to 2,684)
377 (–593 to 2,520)

1,394 (559 to 2,834)
560 (–475 to 2,879)
*Values are in US dollars. DALY, disability-adjusted life year; ICER, incremental cost-effectiveness ratio; govt, governmental costs; soc, societal costs.
†Subnational 1-time immunization campaign for children <15 years of age and subnational routine immunization for 9-month-old children. The subnational approach focuses on 3 divisions with a high number of JE cases: Rangpur, Rajshahi, and Chattogram.
‡Subnational 1-time immunization campaign and national routine immunization.
§National routine immunization only.

Main Article

1These first authors contributed equally to this article.

Page created: August 29, 2024
Page updated: November 20, 2024
Page reviewed: November 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external